Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 October 2021: Original Paper

Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases

Yukihiro Sanada ABCDEF* , Yasunaru Sakuma DF , Yasuharu Onishi B , Noriki Okada B , Naoya Yamada B , Yuta Hirata B , Go Miyahara B , Takumi Katano B , Toshio Horiuchi B , Takahiko Omameuda B , Alan Kawarai Lefor DF , Naohiro Sata DF

DOI: 10.12659/AOT.932994

Ann Transplant 2021; 26:e932994

Table 2 Univariate analysis of risk factors for post-transplant complications in recipients with IMDs and BA.

VariableRecipients with IMDsN=44Recipients with BAN=221p-value
Hepatic vein complications2 (4.5%)15 (6.8%)0.746
Portal vein complications4 (9.1%)38 (17.2%)0.257
Hepatic artery complications2 (4.5%)11 (5.0%)0.999
Biliary complications8 (18.2%)45 (20.4%)0.839
Re-laparotomy after LDLT7 (15.9%)22 (10.0%)0.288
Acute cellular rejection12 (27.3%)98 (44.3%)0.044
Steroid-resistant acute rejection1 (2.3%)26 (11.8%)0.059
Cytomegalovirus viremia22 (50.0%)73 (33.0%)0.039
Post-transplant lymphoproliferative disorder0 (0%)6 (2.7%)0.594
Hospital length of stay62±107 days43±30 days0.125
IMDs – inherited metabolic diseases; BA – biliary atresia; LDLT – living donor liver transplantation.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358